Skip to content
BuyandBill.com — Physician Administered Drug Pricing
  • Search
    • Search
    • HCPCS Code Lookup
    • NDC Lookup
    • Drug Price Lookup
  • Drug Codes
    • All Drug Codes
    • A Code
    • C Code
    • J Code
    • P Code
    • Q Code
    • S Code
    • CPT Vaccine Code
    • NOC Code
    • Administration Code
  • Coding References

    • CPT Administration Codes
    • HCPCS Modifiers
    • HCPCS Approvals
    • Medically Unlikely Edits
    • Place of Service Codes
    • NDC Listing Errors
    • SAD Exclusion List
    • Wastage Guidance

    Learn

    • Blog
    • Newsletter
    • Bobbi Buell's Newsletter
    • Glossary
    • Buy-and-Bill Basics
    • Biosimilars
    • 505(b)(2) Drugs
    • Drug Shortages

    Tools

    • Billing Calculator
    • Drug Comparative Graphing
    • Biosimilar Analysis
    • Part B Reimbursement

    Solutions

    • Drug Sponsorship
    • Drug Market Research
  • Subscription Options
    • Contact Us
    • Schedule Consultation
Login
  • Login
  • Register

Drug Alerts and Special Reports

Key reimbursement alerts for office-administered drugs — C-Code, J-Code, NDC, and NCCN alerts plus pricing updates, sent on behalf of pharma manufacturers.

Subscribe To Newsletter

Pricing 03/10/2023

Price Change for HEPLISAV-B, Hepatitis B Vaccine (Recombinant) - 2/23/23

Announcing a price change for HEPLISAV-B®, {Hepatitis B Vaccine (Recombinant), Adjuvanted} This message is being sent by www.BuyandBill.com on behalf of Dynavax Technologies Effective March 1, 2023 the pricing of HEPLISAV-B ® will change as outlined below. Please take a moment to update any of your reimbursement, billing, and ordering systems to reflect this change. HEPLISAV-B® NDC Code and Pricing: CPT Code 11 Digit NDC Code Effective Date Product Description WAC Per Package WAC Per Syringe Estimated AWP…

Read More
03/10/2023

Lamzede: New Treatment Option Available For Ultra-rare LSD - 2/22/23

New Treatment Option Available For Ultra-rare LSD We are pleased to announce the recent FDA approval of Lamzede® (velmanase alfa-tycv); a recombinant human lysosomal alpha-mannosidase indicated for the treatment of non-central nervous system manifestations of alpha-mannosidosis in adult and pediatric patients.1 AM patients have waited a long time for a treatment option and Chiesi is proud to have it now available for them. Dosage and administration: The recommended dosage is 1mg/kg (actual body weight) administered once every week as an…

Read More
03/10/2023

J1932, injection, lanreotide, (Cipla), has received Pass-Through Status G - 2/1/23

To: Subject: J1932, Lanreotide Injection (Cipla) has received Pass-Through Status G from The Centers for Medicare and Medicaid (CMS) Effective "> J1932, injection, lanreotide, (Cipla), has received Pass-Through Status G from The Centers for Medicare and Medicaid (CMS) From: BuyandBill.com < [email protected] > To: Subject: J1932, Lanreotide Injection (Cipla) has received Pass-Through Status G from The Centers for Medicare and Medicaid (CMS) Effective January 1, 2023: J1932…

Read More
03/09/2023

J1954, injection, leuprolide, (Lutrate), 7.5 mg, is available for all sites of care - 1/4/23

Effective January 1, 2023: J1954 The unique HCPCS code for Cipla USA's LEUPROLIDE ACETATE INJECTION DEPOT (Leuprolide Acetate for Depot Suspension) Effective January 1, 2023: J1954, injection, leuprolide, (Lutrate), 7.5 mg, is available for all sites of care. J1954 is a unique HCPCS code for Cipla's version of LEUPROLIDE ACETATE INJECTION DEPOT (Leuprolide Acetate for Depot Suspension) and sh ould not be used for billing other leuprolide formulations. HCPCS Code HCPCS Code Descriptor NDC Number Strength WAC Per Package HCPCS Units Per…

Read More
03/08/2023

New Indication for Adcetris J9042 - 1/3/23

Announcing a new approval for pediatric patients 2 years and older with previously untreated high risk classical Hodgkin Lymphoma 96 96 Important Safety Information Prescribing Information ADCETRIS ® (brentuximab vedotin) for injection is now approved for use in pediatric patients 2 years and older with previously untreated high risk classical Hodgkin lymphoma (cHL), in combination with doxorubicin, vincristine, etoposide, prednisone and cyclophosphamide. 1 Indication and Recommended Dosage ADCETRIS is a CD30-directed antibody-drug…

Read More
02/14/2023

Teva Products: Updated HCPCS Coding Information - 12/19/22

Teva Products: Updated HCPCS Coding Information Updated HCPCS* Coding Information for Teva Products Effective January 1, 2023, providers should use the new, permanently assigned HCPCS codes for these products, as shown in the tables below. Old/temporary HCPCS codes should not be used after December 31, 2022. Please update your claims processing system and any applicable coverage policies and fee schedules. † Fosaprepitant for Injection…

Read More
Pricing 02/14/2023

Announcing a Price Change for Paragard (intrauterine copper contraceptive) - 12/16/22

Announcing a Price Change for Paragard® (intrauterine copper contraceptive) Paragard Customer, Effective December 31, 2022, the pricing of Paragard will change as outlined below. Please take a moment to update any of your reimbursement, billing, and ordering systems to reflect this change. PARAGARD PRICING AND CODING INFORMATION: HCPCS Code Labeler 11 Digit NDC Price Effective Date Product Description WAC Estimated AWP J7300…

Read More
Pricing 02/14/2023

Important Price Change Announcement for Photrexa - 12/13/22

Important Price Change Announcement for Photrexa® This email is being sent by BuyandBill.com on behalf of Glaukos ® , Inc. Announcing New Pricing for Photrexa ® Cross-Linking Kit As of January 1, 2023 Item Code/Price Description HCPCS Code J2787 Riboflavin 5'-phosphate, ophthalmic solution, up to 3 ml NDC Number 25357-0025-03 A cross linking kit contains one Photrexa Viscous 3 ml single-patient use syringe and one Photrexa solution 3 ml…

Read More
NDC 02/14/2023

New NDC and dose for TURALIO (pexidartinib) - 11/7/22

New NDC and dose for TURALIO® (pexidartinib) (see Prescribing Information and Boxed WARNING) DSI041-TUR-A-02 96 TK ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ TURALIO ® New Dosing Regimen Approved in the U.S. Approved in the U.S. The dosing change is being made due to the known effects food has on the absorption of TURALIO and the potential for drug overexposure that could happen if a patient takes the TURALIO 200…

Read More
NDC 02/14/2023

NEW NDC FOR ZILRETTA (triamcinolone acetonide) - 10/17/22

ACTION REQUIRED: NEW NDC FOR ZILRETTA® (triamcinolone acetonide Pacira BioSciences, Inc. acquired Flexion Therapeutics and ZILRETTA. A new NDC has been issued to reflect the updated labeler code for ZILRETTA . Effective October 10, 2022, a new ZILRETTA NDC will be available: 65250-0003-01 HCPCS Code HCPCS Code Descriptor NDC Number Labeler NDC Description J3304 Injection triamcinolone acetonide, preservative free, extended release…

Read More
Previous
1 … 151617
Next

No alerts match your filters.

BuyandBill.com — Physician Administered Drug Pricing

HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, America's Health Insurance Plans, and Blue Cross and Blue Shield Association).

CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved

Review us on Trustpilot
  • Email us [email protected]

Tools & Lookups

  • Search
  • HCPCS Code Lookup
  • NDC Lookup
  • Drug Price Lookup
  • Billing Calculator
  • Drug Comparative Graphing
  • Biosimilar Analysis
  • Part B Reimbursement
  • All Drug Codes

Coding References

  • CPT Administration Codes
  • HCPCS Modifiers
  • HCPCS Approvals
  • Medically Unlikely Edits
  • Place of Service Codes
  • NDC Listing Errors
  • SAD Exclusion List
  • Wastage Guidance (JZ & JW)

Learn

  • Blog
  • Newsletter
  • Bobbi Buell's Newsletter
  • Glossary
  • Buy-and-Bill Basics
  • Biosimilars
  • 505(b)(2)
  • Drug Shortages

Solutions

  • Drug Sponsorship
  • Drug Market Research

Company

  • About B&B
  • Subscription Options
  • Contact Us
  • Schedule a Consultation
  • Sitemap

© 2026 BuyandBill.com, a product of Alchemy Healthcare Solutions LLC. All rights reserved

  • Privacy Policy
  • Terms of Use
BuyandBill.com Analytics

Chart a whole drug class in one screen.

The Comparative Report puts ASP, the Medicare payment limit, WAC and AWP for up to 15 drugs on one timeline. Ten-plus years of monthly history, per HCPCS unit.

  • Four benchmarks plus the ASP/WAC ratio on the same axis
  • Prebuilt biosimilar, therapeutic-area and mechanism groups
  • Index to 100 to compare a $7 drug against a $90 one
  • Sortable table, reference multiples, saved reports, PDF export
See it in action

Included with BuyandBill Pro for $37/month billed annually.

Trastuzumab class, seven products

7 of 7products fell
▼ 90.0%steepest decline
8.6×price spread
The Comparative Report showing seven trastuzumab products: ASP range $7.73 to $66.27, median $27.16, prices fell 7 of 7, and all seven ASP curves plotted from 2015 to 2026.

Actual published ASP, Jan 2015 to Aug 2026.